Objective: To test the hypothesis that three changes in the early management of extremely low birth weight (ELBW) neonates would decrease the incidence of extra-uterine growth restriction (EUGR) by 25%. The three early management practice changes (EMPC) included surfactant at delivery followed by immediate extubation to nasal continuous positive airway pressure (CPAP), decreased oxygen exposure and early parenteral amino acids.
Introduction
Efforts to implement evidence-based practices in neonatal intensive care units have decreased nosocomial infections, 1 improved perinatal-neonatal communication and collaboration, 2, 3 decreased steroid use and days on mechanical ventilation, 4 improved growth and decreased length of stay. 5 This study investigates the impact of implementing three evidence-based practices into an early management protocol for extremely low birth weight (ELBW) neonates. These early management practice changes (EMPC) included: (1) changing from a respiratory strategy of prophylactic surfactant administration followed by synchronized intermittent mandatory ventilation (SIMV) to a strategy of surfactant administration followed by immediate extubation to nasal continuous positive airway pressure (CPAP) in the delivery room; (2) lowering the goals for oxygen saturation from greater than 95% to 90 to 95% and decreasing the initial FiO 2 from 60 to 40% and (3) starting early amino-acid supplementation on the first day of life compared to the previous practice of dextrose and electrolyte containing solutions followed by a 4 to 6 day advance of amino acids. The primary outcome of interest is the impact of these changes on extra-uterine growth restriction (EUGR), defined as growth less the 10th percentile for postmenstrual age (PMA). 6 Using CPAP as a primary mode of ventilatory support reportedly reduces barotrauma and volutrauma in premature neonates. 7 It is unclear whether using CPAP may facilitate postnatal growth and neurodevelopment, possibly by attenuating ventilator-induced release of inflammatory mediators.
Lowering oxygen saturation ranges has been studied as a means of reducing oxidant injury to the lungs and the retinal vasculature. 8 Not only does this intervention appear safe, but the 'STOP-ROP' (supplemental therapeutic oxygen for pre-threshold retinopathy of prematurity) trial demonstrated that lowered oxygen saturations decreased adverse pulmonary events, such as pneumonia and the need for supplemental oxygen. 9 A recent study has demonstrated a reduction in the incidence of bronchopulmonary dysplasia (BPD) with lowered oxygen saturation goals. 8 Oxygen toxicity may be a significant factor in the etiology of neuronal injury 7 and its role in growth has not been closely examined.
Matching the parenteral nutrition to the ELBW nutrient requirements has improved as our understanding of in utero metabolism and growth has expanded. Inadequate nutritional supplementation is directly linked to EUGR 10, 11 and likely exacerbates recovery and healing from other neonatal morbidities, such as BPD. [12] [13] [14] Early amino-acid supplementation dramatically improves the nitrogen balance of ELBW infants, shifting these patients from the catabolic state traditional parenteral support induces to a healthier anabolic state. [15] [16] [17] The ultimate goal of these three interventions is to improve short-and long-term outcomes. Our primary outcome measure was growth, as EUGR is associated with significantly lower Bayley Mental Development Index (MDI) and Psychomotor Index (PDI) scores at 2 years of age, 18 and impaired long-term growth potential. 19, 20 We also assessed other morbidities associated with long-term complications as an indicator of whether a net benefit was achieved with these three interventions. Intraventricular hemorrhage (IVH) and periventricular leukomalacia (PVL) are linked to cerebral palsy and neurodevelopmental delay. Severe retinopathy of prematurity (ROP) is associated with vision loss. Severe BPD is associated with an increased risk of life-threatening respiratory infection, abnormal pulmonary function testing into late childhood, and an increased risk for neurodevelopmental sequelae compared to babies with mild or no BPD. 21 And, surgical necrotizing enterocolitis (NEC) is associated with neurodevelopmental delay. 22, 23 In this study, we investigated the growth and nutritional parameters in cohorts of neonates born during the 18-month periods before and after the introduction of three EMPC for our ELBW neonates. We tested the hypothesis that initiation of these changes in early management would lead to less EUGR, defined for this study as weight less than the 10th percentile for age at 36 weeks PMA. We also examined the impact of these EMPC on the incidence of morbidities associated with poor long-term outcomes.
Methods

Study design
A retrospective chart review was conducted at the University of Texas Medical Branch (UTMB) in Galveston after approval from the UTMB institutional review board. Study inclusion criteria were infants who were p1000 g, were offered resuscitation, were appropriately sized for gestational age (AGA), were inborn and without congenital malformations. Changes in early management were initiated in the fall of 2003 and infants born in an 18-month period prior to and after the initiation of the changes were compared. Children born in 2003 and the first half of 2004 were excluded to ensure the comparison did not include the transition period after initiation of the new practices. In all, 163 babies met all the inclusion criteria and their charts were reviewed and all data were entered into Microsoft Excel (Microsoft Office Professional edition, 2003, Bellevue, WA, USA). Data collected included demographics, maternal history, birth history and final diagnoses, including diagnosis of BPD and other common morbidities including NEC, IVH and ROP. BPD was further classified for each baby based on the published criteria. 21 In addition, detailed information on parenteral and enteral feedings, growth, length of stay and central line days were collected. Total line days were defined as days with one central line; and if two central lines were in place on the same day, this was counted as one line day. For our statistical analyses, continuous data were analyzed using the Student's t-test, and categorical data were analyzed using w 2 -analysis. The SAS system was used to perform logistic regressions and analysis of variance for repeated measures (User's Guide: Statistics, version 5th edn, SAS Institute Inc.; Cary, NC, 1985) . 
Early management in the post-EMPC cohort
The second group of infants (post-EMPC) was born from July 2004 to December 2005. Changes made to the standardized early management of ELBW infants in the post-EMPC era included: (1) intubation and prophylactic surfactant administration followed by immediate placement on nasal CPAP at 5 cm H 2 O; (2) initiation of 40% FiO 2 followed by a standing order for weaning of FiO 2 by the bedside nurse to maintain oxygen saturations between 90 and 95%; (3) early parenteral amino-acid supplementation with initial intravenous fluids of 10% dextrose with 3% amino acid and calcium gluconate and umbilical artery fluid containing 1 4 normal saline and 1.5% amino acid with heparin. 24 TPN was initiated on the second day of life with 3 gm kg À1 per day of protein instead of the previous graded advance. This parenteral support increased the protein administration in the first 7 days of life from 10 g kg À1 to 20.5 g kg.
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Aspects of our early management of infants under 1000 g that did not change between the two time periods were the prophylactic administration of low-dose indomethacin for IVH prevention for the first 3 days of life, the prophylactic administration of antibiotics, management of hypotension, temperature management and skin care. Permissive hypercapnia was tolerated in both cohorts although early high PCO 2 (>65, <90) in the post-EMPC cohort was often tolerated during the first few hours while stabilizing the infant on CPAP as long as they were breathing comfortably and demonstrating improving PCO 2 levels. After stabilization, blood gases in the post-EMPC group were only done daily and their respiratory status was monitored by the infant's work of breathing and oxygenation. Initiation and advancement of enteral feeds occurred more rapidly in the post-EMPC cohort, although this did not follow any particular guidelines and was faculty dependent. Less postnatal steroids were used in the post-EMPC cohort and it is unclear if this was due to a decreased need for steroids because of changes in the respiratory care or an active attempt to reduce steroid use as concerning evidence emerged regarding its use. Postnatal steroid use was taken into account in our logistic regression. Only one of our six neonatologists changed over the two cohorts.
Primary hypothesis
We predicted that the early changes in clinical practice would decrease the incidence of EUGR by 25%. Using an estimated pre-EMPC EUGR incidence of 40%, an a ¼ 0.05 and a b ¼ 0.2, we calculated a necessary sample size of 70 in each group.
Secondary outcomes
Other outcomes studied included initial weight loss, days to regain birth weight (BW), weight and head circumference at birth, 28 days of life, 36 weeks PMA (or discharge if prior to 36 weeks PMA), total line days, days on TPN, days to achieve full enteral feeds (defined as >110 kcal kg À1 per day), length of stay, incidence of major morbidities (BPD, IVH, NEC, PVL, ROP) and surgeries.
Results
Subjects
Demographic data is shown in Table 1 . The pre-EMPC cohort included 87 babies and the post-EMPC cohort included 76 babies. There were no significant differences in gender, gestational age, BW of survivors, prenatal care, antenatal steroids, maternal chorioamnionitis, pregnancy induced hypertension, multiple births, delivery method or deaths. A total of 13 babies died in the pre-EMPC group and 7 died in post-EMPC group. There was a significant difference in BW between the two cohorts, and we corrected for this confounder in data analysis where appropriate. Infants were excluded from individual outcome measures if they did not survive long enough to attain the diagnosis being measured (for example, BPD or EUGR). BW was not significantly different between cohorts for surviving infants.
Evidence of implementation of practice changes
Evidence that CPAP changes were effectively implemented between the pre-EMPC and post-EMPC cohorts include the following: (1) ELBW infants offered CPAP in the first 24 h of life increased from 1 to 80%, (2) ELBW infants receiving any mechanical ventilation decreased from 99 to 59% and (3) total ventilation days decreased from 35 to 15 days on average. Evidence demonstrating a decreased use of oxygen include the following: total oxygen days decreased from an average of 77 to 56 days, (4) home oxygen use decreased from 26 to 10% and the average FiO 2 was significantly lower throughout hospitalization. This data is fully detailed in Geary et al.
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Outcomes Infants in the pre-EMPC group lost a larger percentage of their BW in comparison to post-EMPC infants (16 ± 7.2 vs 11 ± 7.6%; P<0.001; Table 2 ). The pre-EMPC cohort reached their lowest weight at 7.01 ± 2.08 days compared to 5.62 ± 2.02 days in the post-EMPC cohort (P ¼ 0.0001; Table 2 ). The number of days to regain BW (Table 2 ) was also significantly greater in the pre-EMPC group (16±5.8 vs 12±4.5; P<0.0001). Infants that died prior to demonstrating a reversal in weight loss and infants that died prior to regaining BW were excluded from the percent of BW lost and days to regain BW calculations, respectively.
Enteral feedings were initiated at 6.35 ± 4.6 days in the pre-EMPC cohort compared to 4.82±3.97 days in the post-EMPC cohort (P ¼ 0.03; Table 2 ). Defining full enteral feeds as receiving greater than 110 kcal kg À1 per day in enteral feedings, post-EMPC (Table 2) . Again, infants were excluded from the calculations if they died prior to achieving full feeds. Table 2 shows the mean weight at birth, 28 days and 36 weeks PMA for the survivors in the two cohorts. The post-EMPC cohort gained significantly more weight then the pre-EMPC cohort. At 36 weeks PMA, the mean weight was 1928 ± 321 g for pre-EMPC vs 2166±408 g for post-EMPC, P<0.01. Head circumference was not significantly different between the two groups at birth, 28 days or 36 weeks PMA (23 ± 2.1 vs 24 ± 2 at birth; 25 ± 1.8 vs 26 ± 1.9 at 28 days; and 31±1.4 vs 31±1.7 at 36 weeks).
In the pre-EMPC cohort, 42% of infants were classified as EUGR at 36 weeks PMA (or at discharge if discharged prior to 36 weeks PMA) compared to 18% in the post-EMPC cohort (P<0.003).
Combining infants from both the pre-EMPC and post-EMPC cohorts, we analyzed the infants diagnosed as EUGR to identify risk factors for impaired postnatal growth. Univariate analysis revealed the following significant associations with EUGR: cohort, antenatal steroids, postnatal steroids (for BPD), NEC, BW and days to initiation of feeds (all with P<0.03). Lack of CPAP in the first 24 h and total oxygen days were also significantly associated but are also major contributors of the cohort effect while early amino acids are completely enmeshed with the cohort effect. The following were not associated with EUGR: length of stay, gender, race, prenatal care, pregnancy-induced hypertension, multiple gestation, mode of delivery, maternal chorioamnionitis, maternal use of tobacco, patent ductus arteriousus, intraventricular hemorrhage, gastrointestinal perforation, periventricular leukomalacia.
By multivariate analysis, correcting for the factors identified as significant by univariate analysis, the lower two 125-g BW increments and surgical NEC were the only predictive risk factors for EUGR. Figure 1 shows the distribution of EUGR stratified by 125 g BW categories. The odds ratio (OR) and confidence interval (CI) are listed above each bar graph. These calculations are based upon using the 876 to 1000 g group as the reference group. OR for EUGR in infants with surgical NEC was 3.7 (CI: 1.0 to 14.5). Table 2 compares outcomes related to central line use between the two cohorts including total days on TPN, central line days, days on antibiotics and positive blood culture rates. To be considered positive, both simultaneously drawn cultures were needed to grow the same organism or the peripherally obtained blood culture needed to grow an organism other than coagulase-negative staphylococcus. Table 3 compares the incidence of morbidities and the length of stay between the two cohorts.
To gain an overall sense of how all babies fared with the EMPC, we calculated the incidence of mortality and any morbidity associated with poor long-term outcomes. The morbidities included in this calculation were severe BPD, surgical NEC, grade III or IV intraventricular hemorrhage, periventricular leukomalacia, EUGR and retinopathy of prematurity requiring laser surgery. Infants were considered positive for this attribute if they died or had one or more morbidities. Table 3 shows that the pre-EMPC cohort had 72% of infants with mortality or conditions at high risk for morbidities compared to only 49% in the post-EMPC cohort (P<0.004). Individually, the incidences of EUGR and severe BPD were significantly different between the two cohorts. EUGR and severe BPD accounted for 42 of the 46 infants in the pre-EMPC cohort with impairments, and 20 of the 26 infants in the post-EMPC cohort with impairments. The P-values are indicated in the last column, with P-values less than 0.05 indicated with an asterisk (*). Figure 1 Percent distribution of extra-uterine growth restriction (EUGR) at 36 weeks corrected gestational age by 125 g birth weight increments. Odds ratio (OR) for EUGR and confidence intervals (CI) using the to 876 to 1000 g group as a reference are listed above the bars.
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Discussion
The etiology of EUGR is multifactorial and effective treatment likely requires multiple approaches that reduce illness and injury in addition to supplying appropriate nutritional support. This study found that early management strategies aimed at (1) reducing barotrauma and volutrauma, (2) decreasing oxidant injury and (3) increasing early parenteral amino-acid support significantly reduced the incidence of EUGR and overall neonatal morbidities. Discerning the individual roles of the three EMPC will be best addressed with prospective, single intervention clinical trials, however, synergistic effects of the three changes are likely contributing to the improved outcomes. Successful implementation of major changes in care for neonates is challenging when there are many levels of care providers. Weekly meetings amongst our faculty, fellows, nurse managers and pharmacist seemed to greatly enable consensus decisions to be made along with plans for implementation of uniform changes in care. Introducing CPAP and lower oxygen goals for ELBW infants required bedside education and encouragement along with formal educational lectures for the nursing staff and the pediatric residents. Once educated and encouraged to help learn how to optimize these new therapies, the process of transitioning to the new management plans seemed to take care of itself. The change in admission of intravenous fluids was accomplished by taking 'leftover' amino acids that would normally be discarded in our pharmacy and mixing it with 10% dextrose and calcium gluconate. These 'Admit Fluids' were then stored in our unit and easily became the fluids hung upon admission for our premature infants. The same process occurred for adding amino acids to our umbilical line fluids and for creating 'Admit Lyte' solution with sodium and potassium for transitioning neonates off of TPN.
Early management changes enhanced growth parameters almost immediately as evidenced by less weight loss after birth and an earlier regaining of BW. Similar results have been reported with the introduction of early amino acids suggesting that this intervention alone may be responsible for the improvement in early growth. [26] [27] [28] [29] It is possible that the stress on the ELBW neonate losing 16% of their BW and weight loss continuing for 7 days of life may be setting the stage for the increase morbidities seen in the pre-EMPC cohort. The tolerance of an earlier initiation of feeds among neonates on CPAP and less oxygen may be related to the fact that these are less stressful interventions for these very immature infants. Attaining full feeds 8 days sooner may also reflect improved tolerance to feeding advancement.
While days of TPN were similar between cohorts, the quantity of early amino acids supplied in the first week of life was doubled, as neonates in the pre-EMPC cohort were on dextrose solutions and then a slow advancement of amino acids during this time. Although the total line days decreased, we did not see a decrease in antibiotic use or a decrease in the number of positive cultures seen in each patient. Two studies found a decreased incidence of culture proven sepsis with introduction of early TPN, however the incidence of sepsis in both studies decreased to rates comparable to that found in both our cohorts. 26, 27 All infants in both cohorts were born with a head circumference that was appropriate for their gestational age, but the average head circumference at 36 weeks PMA was only at the 20th percentile for both cohorts. In the pre-EMPC cohort, these initially AGA infants had an average weight at 36 weeks that was 200 g below the 10th percentile, qualifying as EUGR while the post-EMPC cohort had an average weight at 36 weeks that was at the 10th percentile. All of these early management changes still failed to match in utero growth and maintain optimal growth potential. The enhanced growth velocity in the post-EMPC group likely relates to the early anabolic state achieved with use of early amino acids. 17, 27, 28, 30 In addition, the decreased energy required for healing from barotrauma, volutrauma and oxidant injury with use of CPAP and decreased oxygen saturation ranges is likely contributing to the enhanced growth.
Suboptimal growth is almost universal among ELBW infants. Inadequate nutrient intake, cumulative energy and protein deficit in the initial days, severity of illness and concurrent drug administration are suspected in the pathogenesis of growth failure. EUGR has been associated with low MDI, low PDI) and low intelligence quotient at school age, behavioral problems, poor attention and poor receptive language scores. 18, 31 In addition EUGR in the neonatal period is associated with short stature into adulthood, and poor head growth. 18 Given these long-term risks of EUGR, it is important to identify early predictors of EUGR so that Pulmonary morbidities significantly decreased in the post-EMPC cohort. This data are presented extensively in a separate article. 25 The significant decrease in inguinal hernia repairs was surprising, but may be related to the decreased incidence of BPD with a decrease in abdominal pressure. 36 To gain an overall sense of how all babies fared with the EMPC, a cumulative mortality and morbidity index was created. This is a crude estimate, as it is not weighted for the severity of the morbidity/mortality. Any infant with mortality or any morbidity known to have long-term sequelae was included. Although dramatically improved from 72%, at least 49% of our ELBW infants continue to be at risk for known long-term complications of their prematurity.
The major limitation of this study is the use of an historical cohort when examining the complex processes involved in caring for ELBW neonates. The retrospective nature of the study requires reliance on accurate and complete documentation. Although not significant in our multivariate analysis, other limitations include changes in postnatal steroid use and minor changes in the use of insulin, both of which can impact growth. In addition, this study examines three major changes in their care making it impossible to delineate the impact of each individual change. These limitations would be best addressed with prospective single intervention randomized trials, however this may not allow for identifying synergistic influences of care changes. Our efforts to further reduce EUGR and optimize growth involve being more aware of suboptimal growth, prolonging the use of small amounts of TPN and by increasing the caloric goals of infants that are developing EUGR (>120 kcal kg À1 per day).
